Latest News
United Therapeutics Corporation
- Form 4 United Therapeutics Corporation: Martine A. Rothblatt (Director, Chairperson & CEO) For: 21 October
- United Therapeutics Opens New Facility at Generation Park
- United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
- United Therapeutics authorizes $2 billion buyback program By Investing.com
- United Therapeutics Authorizes Up to $2 Billion Share Repurchase
- United Therapeutics chairperson & CEO sells $5.08m in shares By Investing.com
- StockWatch: Liquidia Rebounds After Settling Legal Wrangle with United Therapeutics
- Liquidia Settles With United Therapeutics; $320.4M Payments, PH-ILD Indication Removed
- United lands 'clear-cut win' as Liquidia agrees to $380M settlement in Tyvaso patent infringement saga
- Liquidia surges as United Therapeutics settlement removes key litigation risk
- Liquidia slumps after US court rules for United Therapeutics in patent fight
- United Therapeutics stock rises nearly 13% as FDA accepts supplemental Tyvaso application
Headlines from the last 30 days, linking to the original publishers. See all market news →